DELIVERY ORDER
Active75F40126F19003
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$309.1K
obligated · signed 2 months ago
EO 14398 - POST-MARKETING RX DRUG ABUSE SURVEILLANCE DATA
Performance timeline
Start
Sep 28, 2026
End
Sep 27, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 27, 2027
INTEGRATED BEHAVIORAL HEALTH, INC.
Contract 75F40126F19003
UEI
L9YZF5SG6WN1
Parent Company
INTEGRATED BEHAVIORAL HEALTH, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 47
Current Obligation
$309,073
Base + Exercised Options
$309,073
Total Ceiling Value
$309,073
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40121D00032
IDCDepartment of Health and Human Services
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.